EUCAST proposes to change the definition and usefulness of the susceptibility category ‘Intermediate’

Clinical Microbiology and Infection

Volumn 23, Issue 12, 2017, Pages 894-895

  Kahlmeter, G ^a  

^a EUCAST Development Laboratory   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CONSULTATION; ENTEROBACTERIACEAE; ENTEROCOCCUS; HAEMOPHILUS; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; THERAPY EFFECT; URINARY TRACT INFECTION; BACTERIUM; DRUG EFFECT; FUNGUS; MICROBIAL SENSITIVITY TEST; STANDARDS; TRENDS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; FUNGI; MICROBIAL SENSITIVITY TESTS;

EID: 85028655103     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2017.08.015     Document Type: Note

References (3)

1. EUCAST European Committee on Antimicrobial Susceptibility Testing. Proposed modifications to EUCAST definition of the intermediate category, 2016 http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation/2016/20160919_Intermediate_consultation_comments_and_responses.pdf.
2. Kahlmeter, G., Brown, D.F., Goldstein, F.W., MacGowan, A.P., Mouton, J.W., Osterlund, A., et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 52 (2003), 145–148.
3. EUCAST European Committee on Antimicrobial Susceptibility Testing. Proposed modifications to EUCAST definition of the Intermediate category 2nd consultation, 2017 http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation/2017/Intermediate_category_-_2nd_consultation_2017.pdf.